

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Coagulation Factor X
Therapeutic Area : Hematology
Study Phase : Phase III
Sponsor : Worldwide Clinical Trials
Deal Size : Inapplicable
Deal Type : Inapplicable
A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis
Details : Coagadex (Coagulation Factor X) is a drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Factor X Deficiency.
Product Name : Coagadex
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 08, 2025
Lead Product(s) : Coagulation Factor X
Therapeutic Area : Hematology
Highest Development Status : Phase III
Sponsor : Worldwide Clinical Trials
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Coagulation Factor X (Human),Coagulation Factor X
Therapeutic Area : Hematology
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
BPL Receives Orphan Drug Marketing Authorization for Coagadex® in Mexico
Details : Coagadex® is the first and only treatment specifically for Hereditary Factor X Deficiency, a very rare inherited clotting disorder that causes problems with blood clotting due to not having enough Factor X in the blood.
Product Name : Coagadex
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 04, 2022
Lead Product(s) : Coagulation Factor X (Human),Coagulation Factor X
Therapeutic Area : Hematology
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
